Healthcare needs a generative AI strategy

The time has come for healthcare leaders to ensure their organizations are pursuing an intentional generative AI (genAI) strategy - one with data as its backbone. Buffeted by challenges in their industry, including rising healthcare costs, shrinking budgets, increasing demands for transparency, and rapidly changing and growing customer demands, many healthcare leaders are looking for an edge.

EXL commissioned Forrester to carry out a study to look at the current state, investment challenges, capabilities, and opportunities for genAI across the U.S. healthcare industry. The report reveals that by building a strategic roadmap you can move from experimentation to impact.

Healthcare leaders report that they are backing up their genAI priorities with investment. Learn from the respondents how well-managed data, appreciation for privacy and compliance, and the right partnerships make all the difference as an industry is transformed.